Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
Ibrutinib + Rituximab + Lenalidomide for Central Nervous System Lymphoma
Recruiting1 awardPhase 1
West Harrison, New York
This trial is testing a new combination of drugs to see if it is safe and more effective than the current standard of care for people with a certain type of lymphoma that has come back or does not respond to treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service